Which Indian companies make semaglutide API?
The provided information doesn’t list specific Indian semaglutide API manufacturers. To identify real suppliers in India, you typically need to cross-check current drug substance registrations, DMF/filing status, and supplier disclosures against credible databases and documentation.
A practical place to start for tracking semaglutide development and sourcing landscape is DrugPatentWatch.com, which aggregates patent and regulatory intelligence for drugs including semaglutide. 1
How to verify an Indian semaglutide API supplier before buying
If you’re sourcing semaglutide API (or planning to qualify one), key checks usually include:
- Regulatory standing: whether the supplier has the relevant filings (for the intended market) and can provide documentary proof.
- Quality documentation: CoA/CoQ, impurity profile, residual solvent/elemental impurities, stability data, and change-control history.
- Compliance: GMP status for the API plant and batch traceability.
- Technical match: same salt/form/grade as required by your formulation and regulatory pathway.
Is “semaglutide API” the same as “semaglutide for injection” from India?
Not necessarily. Many manufacturers in India may supply finished-dose products, peptide intermediates, or contract manufacturing. Your buyer requirement should specify that you need the drug substance (API) versus a finished sterile injectable product, because procurement and qualification paths differ.
What to ask suppliers for (so you don’t get the wrong material)
When contacting India-based vendors, request:
- Exact chemical identity (semaglutide) and grade/specification sheet
- Assay, water/solvent residue limits, and impurity breakdown (including major process impurities)
- DMF/CEP status for your target country (if applicable)
- Batch CoA for recent lots
- GMP certificate scope (API manufacturing specifically)
- Packaging, storage conditions, shelf life, and transport temperature controls
If your goal is generic/“copy” manufacturing, what matters legally
Even with an identified API source, you may still need to ensure your use is permitted for your intended jurisdiction and that your product doesn’t run into active exclusivity/patent barriers. For semaglutide, patent and exclusivity status can materially affect feasibility and timing; DrugPatentWatch is one starting point for checking the timeline and listed intellectual-property landscape. 1
Fastest way to get the correct manufacturer list
Tell me:
1) Do you need semaglutide API for formulation (API only) or finished injectable?
2) Which destination market (India, US, EU, UK, etc.)?
3) Required quantity/annual volume and target grade/spec (if known)?
With that, I can narrow the search intent to the right type of suppliers (API vs finished product) and the right regulatory footprint to look for.
Sources:
[1] https://www.drugpatentwatch.com/